Skip to content
  • Global Key Solutions is now KeyPedia →
  • Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Use →
  • KeyPedia Launches openFDA MCP Connector With an "Elsa for Industry" Approach →
  • KeyPedia Listed in TPRA’s TPRM Tools List →
  • Global Key Solutions is now KeyPedia →
  • Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Use →
  • KeyPedia Launches openFDA MCP Connector With an "Elsa for Industry" Approach →
  • KeyPedia Listed in TPRA’s TPRM Tools List →
KeyPediaKeyPedia
  • Company
  • Platform
  • Media
  • KeyPedia Lite
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. BioMarin Pharmaceutical, Inc.
FDA Inspection•BioMarin Pharmaceutical, Inc.•December 14, 2017

BioMarin Pharmaceutical, Inc. – FDA Inspection, Dec 14, 2017

Record Details

This FDA Inspection record concerns BioMarin Pharmaceutical, Inc., with an inspection on December 14, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
BioMarin Pharmaceutical, Inc.
Inspection Date
December 14, 2017
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Ashar P. Parikh
  • Jolanna A. Norton (FDA Associated Person)
  • Joslyn K. Brunelle (Company Rep)
  • Ying Xin Fan (Issuing Officer)

ID · 294a4562-e09d-41ef-b5da-6e26860ddf6d

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1041169
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

Other FDA inspections of BioMarin Pharmaceutical, Inc.

11
DateClassificationOfficeProject area
March 26, 2025Not classifiedSan Francisco District Office
August 19, 2024VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 9, 2018Not classifiedSan Francisco District Office
November 4, 2016NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
April 17, 2014VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 11 other inspections on the company page

Other documents for BioMarin Pharmaceutical, Inc.

5
Document
FDA Inspection 1268309 · March 26, 2025 
FDA Inspection 1251795 · August 19, 2024 
FDA Inspection 1076844 · November 9, 2018 
FDA Inspection 991276 · November 4, 2016 
FDA Inspection 878935 · April 17, 2014 
View Company ProfileHave an account? Sign in to open in Dashboard

Or discuss it with

What you get

  1. A document

    One file.

    • One FDA document, such as a Form 483
    • Yours for life in your Library
    • Each has its own price
    here
  2. The profile

    All the documents, plus intelligence about the company.

    • Every BioMarin Pharmaceutical, Inc. document on file
    • The KRA score, which a single document does not include
    • Observations and inspection history
  3. Access

    This, for every company on KeyPedia.

    • Combine profiles in one search
    • Search across any modality: products, industry types, drugs, devices and recalls
    • Track everything as it changes
    • Other agencies too, such as EMA, Health Canada and UK MHRA
    Browse free in KeyPedia Lite
KeyPedia
The intelligence layer for life sciences
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
Quick Links
HomePlatformUse CasesHardwarePricingResearchOur TechnologyFAQMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPrograms & Partnerships
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.